scholarly article | Q13442814 |
P50 | author | Shaun Flint | Q48264640 |
K G Smith | Q52055719 | ||
Paul A Lyons | Q87690619 | ||
P2093 | author name string | James C Lee | |
Julian Thumboo | |||
Anselm Mak | |||
Boon Wee Teo | |||
Eoin F McKinney | |||
Kok Yong Fong | |||
David M Kemeny | |||
Vojislav Jovanovic | |||
Paul MacAry | |||
David Rw Jayne | |||
P2860 | cites work | Interferon gene expression signature in rheumatoid arthritis neutrophils correlates with a good response to TNFi therapy | Q42775345 |
Type-I IFN drives the differentiation of short-lived effector CD8+ T cells in vivo. | Q50982101 | ||
Type I IFN negatively regulates CD8+ T cell responses through IL-10-producing CD4+ T regulatory 1 cells | Q56881042 | ||
Type I interferons produced by dendritic cells promote their phenotypic and functional activation | Q61473768 | ||
Type I IFNs inhibit human dendritic cell IL-12 production and Th1 cell development | Q74515353 | ||
Blockade of TLR9 agonist-induced type I interferons promotes inflammatory cytokine IFN-gamma and IL-17 secretion by activated human PBMC | Q79278179 | ||
Leukocyte gene expression signatures in antineutrophil cytoplasmic autoantibody and lupus glomerulonephritis | Q80715700 | ||
WGCNA: an R package for weighted correlation network analysis | Q21284194 | ||
Constitutive type I interferon modulates homeostatic balance through tonic signaling | Q28260631 | ||
Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus | Q29614922 | ||
Microarray analysis of human leucocyte subsets: the advantages of positive selection and rapid purification | Q33276937 | ||
A type I interferon transcriptional signature precedes autoimmunity in children genetically at risk for type 1 diabetes. | Q33789317 | ||
Novel expression signatures identified by transcriptional analysis of separated leucocyte subsets in systemic lupus erythematosus and vasculitis | Q34110028 | ||
Modular transcriptional repertoire analyses of adults with systemic lupus erythematosus reveal distinct type I and type II interferon signatures | Q34149941 | ||
Development of Potential Pharmacodynamic and Diagnostic Markers for Anti-IFN-α Monoclonal Antibody Trials in Systemic Lupus Erythematosus | Q34177087 | ||
SLE peripheral blood B cell, T cell and myeloid cell transcriptomes display unique profiles and each subset contributes to the interferon signature | Q34796327 | ||
Genome-wide DNA methylation analysis of systemic lupus erythematosus reveals persistent hypomethylation of interferon genes and compositional changes to CD4+ T-cell populations | Q34945629 | ||
Interferon signature in the blood in inflammatory common variable immune deficiency | Q34999382 | ||
Cell-specific type I IFN signatures in autoimmunity and viral infection: what makes the difference? | Q35082621 | ||
Gene expression profiling of CD8+ T cells predicts prognosis in patients with Crohn disease and ulcerative colitis | Q35381299 | ||
Widely divergent transcriptional patterns between SLE patients of different ancestral backgrounds in sorted immune cell populations | Q35688808 | ||
A CD8+ T cell transcription signature predicts prognosis in autoimmune disease | Q36417832 | ||
Neutrophil function: from mechanisms to disease | Q37973773 | ||
Type I IFN system in the development and manifestations of SLE. | Q38029509 | ||
The Contribution of Transcriptomics to Biomarker Development in Systemic Vasculitis and SLE. | Q38377848 | ||
P4510 | describes a project that uses | WGCNA | Q102537983 |
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | e000183 | |
P577 | publication date | 2016-05-16 | |
P1433 | published in | RMD open | Q27726913 |
P1476 | title | Leucocyte subset-specific type 1 interferon signatures in SLE and other immune-mediated diseases | |
P478 | volume | 2 |
Q52593114 | A novel two-score system for interferon status segregates autoimmune diseases and correlates with clinical features. |
Q38930224 | A systems approach to renal inflammation in SLE. |
Q57461456 | Gene expression profiling comes closer to the clinic |
Q39018269 | Immunopathogenesis of systemic lupus erythematosus and rheumatoid arthritis: the role of aberrant expression of non-coding RNAs in T cells |
Q61811446 | Multiplexed enrichment and genomic profiling of peripheral blood cells reveal subset-specific immune signatures |
Q64099913 | New Attempts to Define and Clarify Lupus |
Q90412368 | New therapeutic strategies in systemic lupus erythematosus management |
Q98205392 | Transcriptomic profile of adverse neurodevelopmental outcomes after neonatal encephalopathy |
Search more.